Simplify Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Simplify Asset Management Inc.

$1.77 Billion
Q3 2025

A detailed history of Simplify Asset Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 12,981 shares of REGN stock, worth $7.52 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

12,981

Previous 3,697 251.12%

Holding current value

$7.52 Million

Previous $1.94 Million 276.19%

% of portfolio

0.41%

Previous 0.11%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$534.91 - $598.71 $4.97 Million - $5.56 Million	9,284 Added 251.12%	12,981 $7.3 Million
Q2 2025 Aug 07, 2025	BUY	$483.07 - $625.6 $453,602 - $587,438	939 Added 34.05%	3,697 $1.94 Million
Q1 2025 May 13, 2025	SELL	$634.14 - $744.83 $2.22 Million - $2.61 Million	-3,500 Reduced 55.93%	2,758 $1.75 Million
Q4 2024 Feb 11, 2025	SELL	$701.85 - $1046.91 $2.34 Million - $3.49 Million	-3,333 Reduced 34.75%	6,258 $4.46 Million
Q3 2024 Nov 06, 2024	BUY	$1024.09 - $1201.76 $3.31 Million - $3.88 Million	3,231 Added 50.8%	9,591 $10.1 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $2.92 Million - $3.55 Million	3,310 Added 108.52%	6,360 $6.68 Million
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $864,777 - $951,629	-958 Reduced 23.9%	3,050 $2.94 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $227,902 - $259,219	-294 Reduced 6.83%	4,008 $3.52 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $403,698 - $492,267	583 Added 15.68%	4,302 $3.54 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $58,102 - $68,919	-83 Reduced 2.18%	3,719 $2.67 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $90,505 - $109,987	-133 Reduced 3.38%	3,802 $3.12 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $222,355 - $241,412	315 Added 8.7%	3,935 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $645,716 - $814,860	1,125 Added 45.09%	3,620 $2.49 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $1.37 Million - $1.84 Million	2,495 New	2,495 $1.48 Million

Others Institutions Holding REGN

# of Institutions

1,433

Shares Held

88.8M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $62.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.

Account

Simplify Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History